Peptides DB
Research-centric peptide and protocol reference hub
Study 32 of 32VIP (Vasoactive Intestinal Polypeptide) literaturebiorxiv-preprint · Observational2026

Atlas-Guided Cell-Specific Transcriptomics Identifies Pathway-Level Remodeling of Human Hypothalamic CRH Neurons in Opioid Use Disorder

This study highlights changes in the molecular profile of CRH neurons in opioid use disorder, including a decrease in vasoactive intestinal polypeptide, but does not provide direct functional implications.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the vip (vasoactive intestinal polypeptide) corpus
7
Preclinical
19
Observational · this one
0
Open-label
2
Randomised
4
Reviews

Summary and findings

This study examined the molecular state of human paraventricular nucleus corticotropin-releasing hormone neurons in opioid use disorder using single-nucleus RNA sequencing of 343,819 human hypothalamic nuclei. The analysis identified changes in neuropeptide levels, including nominal decreases in vasoactive intestinal polypeptide (VIP). The findings suggest pathway-level remodeling in these neurons associated with opioid use disorder.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Nominal decrease in VIP, not quantified.n=3438192026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Opioid use disorder (OUD) disrupts hypothalamic stress signaling, yet the molecular state of human paraventricular nucleus (PVN) corticotropin-releasing hormone (CRH) neurons remains poorly defined. Using single-nucleus RNA sequencing of 343,819 human hypothalamic nuclei, we applied complementary human HYPOMAP/MapMyCells and mouse PVN Atlas strategies that independently converged on the standardized Allen Brain Map subcluster Splat 410 843, providing cross-atlas validation of a rare CRH-enriched PVN population. Integrated GO, Reactome and KEGG analysis revealed OUD-associated enrichment of synaptic, junctional, cytoskeletal, receptor-signaling and ion transport programs, with relative enrichment of RNA processing, ER Golgi/vesicular, endolysosomal and glycan-related functions in controls. Targeted neuropeptide analysis further identified nominal increases in OXT, GHR, GAL and PRLR and decreases in VIP, AGRP, NPY, CRHBP and CALCR. Together, these findings define a reproducible human PVN CRH population and identify coordinated pathway and neuropeptide remodeling in OUD.

Background

Opioid use disorder (OUD) is known to disrupt hypothalamic stress signaling, but the specific molecular alterations in human paraventricular nucleus (PVN) corticotropin-releasing hormone (CRH) neurons are not well understood. Previous studies have focused on animal models, leaving a gap in knowledge regarding human-specific changes. This study aims to address this gap by utilizing advanced transcriptomic techniques to characterize the state of CRH neurons in the context of OUD.

Methods

The study employed single-nucleus RNA sequencing to analyze 343,819 human hypothalamic nuclei. The population studied consisted of human hypothalamic tissues, although specific demographic details were not provided. The analysis included the application of HYPOMAP/MapMyCells and mouse PVN Atlas strategies for cross-validation. Primary outcomes included the identification of neuropeptide levels and pathway enrichment associated with OUD.

Results

The study identified nominal increases in neuropeptides OXT, GHR, and GAL, while VIP, AGRP, NPY, CRHBP, and CALCR showed nominal decreases. Specific numeric changes were not reported in the abstract. The analysis revealed OUD-associated enrichment of various biological pathways, including synaptic and receptor-signaling programs.

Interpretation

The findings suggest that OUD is associated with significant remodeling of neuropeptide expression in human CRH neurons, which may have implications for understanding the neurobiological underpinnings of stress responses in OUD. However, the nominal nature of the changes raises questions about their clinical significance. The reliance on RNA sequencing data and the absence of functional validation limit the conclusions that can be drawn from this study.

Key findings

  • 343,819 human hypothalamic nuclei analyzed.
  • Nominal increase in OXT, GHR, GAL.
  • Nominal decrease in VIP, AGRP, NPY, CRHBP, CALCR.

Limitations

  • Single-nucleus RNA sequencing may not capture functional implications.
  • Nominal changes in neuropeptide levels may not be clinically significant.
  • Specific demographic details of the human population were not reported.

Elsewhere in the VIP (Vasoactive Intestinal Polypeptide) corpus

DBinary classification of sake acidity using excitation-emission matrix fluorescence spectroscopy combined with multivariate analysis models.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2026 · n=100 · Accuracy 0.880.ASafety and efficacy of Meridian sinew tuina (MST) for post-surgical upper limb lymphedema: a systematic review and meta-analysis.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2026 · n=1114 · SMD = 1.59; 95% CI: 1.44 to 1.74; Z = 20.81; p < 0.0001; N = 924.reviewBAccuracy and feasibility of robot-assisted implant surgery in edentulous patients: A retrospective case series.Journal of dentistry · 2026 · n=15 · Mean linear deviations were 0.71 ± 0.23 mm at the implant neck and 0.74 ± 0.24 mm at the apex.HumanBPredictions and cross-center validation of IDH status and 1p/19q status in adult diffuse glioma with non-invasive magnetic resonance spectroscopy.Magnetic resonance letters · 2026 · n=268 · IDH prediction AUCs: 0.906 intra-center, 0.857 cross-center.HumanBExpression and Correlation Analysis of Neuropeptide Family Members in the Peripheral Blood of Patients with COVID-19.Current pediatric reviews · 2026 · ACE2 in non-COVID-19 and moderate COVID-19 groups was higher than that in severe groups (p=0.04; p=0.03, respectively).HumanCVasoactive intestinal peptide attenuates form-deprivation myopia in guinea pigs by suppressing the Wnt/β-catenin pathway along the retina-choroid-scleral axis.Experimental eye research · 2026 · Not reported in abstract.Animal